Stocks Health care GOVX
NASDAQ · Health careGeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc. brought in $0 of revenue over the twelve months to June 30, 2026, down 100.0% from a year earlier. It posted a net loss of $20.4M. In fiscal 2025 capital spending exceeded operating cash flow by $21.5M. At June 30, 2026 it held $3.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 27, 2026.
What GeoVax Labs, Inc. does
GeoVax Labs, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GOVX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.5M | -$21.5M | -$22.40 | -$21.5M |
| 2024 | $4M | -$25M | -$120.46 | -$24.7M |
| 2023 | $0 | -$26M | -$357.13 | -$25.2M |
| 2022 | $81.5K | -$14M | -$309.65 | -$19.2M |
| 2021 | $385.5K | -$18.6M | -$75.97 | -$11.2M |
| 2020 | $1.8M | -$3M | -$53.48 | -$2.9M |
Full financial statements: income, balance sheet and cash flow
Where GOVX ranks in Health care
Latest SEC filings
What GeoVax Labs, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026IPO registration S-1
- September 10, 2026Proxy statement DEF 14A
- September 10, 2026Other event 8-K
- August 31, 2026Preliminary proxy statement PRE 14A
- August 28, 2026
- August 28, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 10, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running GeoVax Labs, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about GOVX
What does GeoVax Labs, Inc. do?
GeoVax Labs, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GOVX.
Is GeoVax Labs, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $20.4M.
How much revenue does GeoVax Labs, Inc. make?
Over the twelve months to June 30, 2026 GeoVax Labs, Inc. reported revenue of $0. That is 100.0% less than a year earlier.
When did GeoVax Labs, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 27, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the iPO registration from September 17, 2026.
Similar companies
Compare GOVX with
Follow GOVX
Get an email when GeoVax Labs, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow GOVX: get an email when it filesWhere the numbers come from
Financial figures are the values GeoVax Labs, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.